摘要
目的 观察以泰索帝为主的联合化疗方案治疗晚期非小细胞肺癌及乳腺癌的临床疗效和毒性反应。方法 泰索帝的剂量为 75mg/m2 ,静脉滴注 1h ,用泰索帝 2 4h前口服地塞米松 8mg ,2次 /d ,连服 3d。肺癌联合顺铂 90mg/m2 ,乳腺癌联合阿霉素 40mg/m2 ,2 1d为 1个周期 ,治疗 2个周期。结果 非小细胞肺癌 15例 ,PR 6例 ,NC 7例 ,PD 2例 ,有效率 40 0 % ;乳腺癌 9例 ,CR 2例 ,PR 6例 ,NC 1例 ,有效率 88.9%。全组 2 4例 ,有效 14例 ,总有效率 5 8.3%。毒性反应主要为白细胞减少、腹泻、乏力、肌肉痛和脱发。白细胞减少达到Ⅲ、Ⅳ度的分别是 9例和 4例 ,血红蛋白和血小板减少较轻 ,无Ⅲ、Ⅳ度者 ;腹泻 19例 ,达到Ⅲ、Ⅳ度的分别是 7例和 3例 ;Ⅲ度过敏反应 1例。结论 以泰索帝为主联合化疗治疗晚期非小细胞肺癌和乳腺癌具有较好疗效。毒性反应轻 ,耐受性好。
Objective To observe the response rate and toxic reaction of taxotere in the treatment of advanced NSCLC and breast cancer.Methods A total of 24 cases was included in the study. Taxotere 75 mg/m 2 iv drip for 1 hour; dexamethasone 8 mg bid 24 hour before taxotere, and continued for 3 days. For NSCLC, the taxotere was combined with DDP 90 mg/m 2; for breast cancer, it was combined with ADM 40 mg/m 2. The second treatment cycle was given after 3 weeks. At last 2 cycles were given.Results In 15 NSCLC patients, there were 6 PR, 7 NC and 2 PD. In 9 breast cancer patients, there were 2 CR, 6 PR and 1 NC. The major toxic reactions were neutropenia, diarrhea, fatigue, muscle pain and alopecia. Grade 3 and grade 4 neutropenia occurred in 9 and 4 cases, respectively. Decrease in hemoglobin and thrombocytopenia were mild. Diarrhea occurred in 19 cases and allergic reaction in 1 case.Conclusion Taxotere is effective in the combined treatment of advanced NSCLC and breast cancer. The toxic reactions are tolerable. Subject
出处
《中华肿瘤杂志》
CAS
CSCD
北大核心
2000年第2期168-169,共2页
Chinese Journal of Oncology
关键词
肺肿瘤
药物疗法
非小细胞肺癌
乳腺癌
泰索帝
Lung neoplasms/drug therapy
Carcinoma, non small cell lung/drug therapy
Breast neoplasms/drug therapy
Taxotere/therapeutic use
